Back to Search
WILLIAM ROSE, MD
MD
Emergency Medicine Physician
NPI: 1871541201IndividualAccepts Medicare
Specialties, Licenses & Credentials
Emergency Medicine PhysicianPrimary
Emergency Medicine
Code: 207P00000X
35.071985(OH)17964(WV)
Education
NORTHEASTERN OHIO UNIVERSITY COLLEGE OF MEDICINE
Class of 1990
Research & Publications (20)
Acute pancreatitis as the initial presentation in pediatric systemic lupus erythematosus.
PMID 19475344·Indian J Pediatr·2009
5-case
Impact of inoculum size and heterogeneous vancomycin-intermediate Staphylococcus aureus (hVISA) on vancomycin activity and emergence of VISA in an in vitro pharmacodynamic model.
PMID 19015334·Antimicrob Agents Chemother·2009
8-other
Impact of biofilm on the in vitro activity of vancomycin alone and in combination with tigecycline and rifampicin against Staphylococcus aureus.
PMID 19109338·J Antimicrob Chemother·2009
8-other
Evaluation of daptomycin pharmacodynamics and resistance at various dosage regimens against Staphylococcus aureus isolates with reduced susceptibilities to daptomycin in an in vitro pharmacodynamic model with simulated endocardial vegetations.
PMID 18591272·Antimicrob Agents Chemother·2008
8-other
Teicoplanin pharmacodynamics in reference to the accessory gene regulator (agr) in Staphylococcus aureus using an in vitro pharmacodynamic model.
PMID 18263568·J Antimicrob Chemother·2008
8-other
daptomycin activity against Staphylococcus aureus following vancomycin exposure in an in vitro pharmacodynamic model with simulated endocardial vegetations.
PMID 17999971·Antimicrob Agents Chemother·2008
8-other
Evaluation of daptomycin treatment of Staphylococcus aureus bacterial endocarditis: an in vitro and in vivo simulation using historical and current dosing strategies.
PMID 17540670·J Antimicrob Chemother·2007
7-preclinical
Correlation of vancomycin and daptomycin susceptibility in Staphylococcus aureus in reference to accessory gene regulator (agr) polymorphism and function.
PMID 17434881·J Antimicrob Chemother·2007
8-other
Novel fluoro-substituted camptothecins: in vivo antitumor activity, reduced gastrointestinal toxicity and pharmacokinetic characterization.
PMID 16228206·Cancer Chemother Pharmacol·2006
7-preclinical
Tigecycline: first of a new class of antimicrobial agents.
PMID 16863487·Pharmacotherapy·2006
6-review
Using an integrated approach to link biomarker responses and physiological stress to growth impairment of cadmium-exposed larval topsmelt.
PMID 17083987·Aquat Toxicol·2006
4-observational
Validation of otolith growth rate analysis using cadmium-exposed larval topsmelt (Atherinops affinis).
PMID 16268164·Environ Toxicol Chem·2005
7-preclinical
Therapeutic synergy of oral taxane BMS-275183 and cetuximab versus human tumor xenografts.
PMID 15534118·Clin Cancer Res·2004
7-preclinical
Preclinical antitumor activity of BMS-214662, a highly apoptotic and novel farnesyltransferase inhibitor.
PMID 11606387·Cancer Res·2001
7-preclinical
Persistence of benzo[a]pyrene--DNA adducts in hematopoietic tissues and blood of the mummichog, Fundulus heteroclitus.
PMID 11239691·Aquat Toxicol·2001
7-preclinical
Preclinical antitumor activity of two novel taxanes.
PMID 11269747·Cancer Chemother Pharmacol·2001
7-preclinical
Preclinical pharmacology of BMS-275183, an orally active taxane.
PMID 11448919·Clin Cancer Res·2001
4-observational
Preclinical oral antitumor activity of BMS-185660, a paclitaxel derivative.
PMID 11021743·Cancer Chemother Pharmacol·2000
4-observational
Prolonged neurologic course of familial hemophagocytic lymphohistiocytosis.
PMID 19664539·Pediatr Neurol·2009
5-case
Data courtesy of the U.S. National Library of Medicine (NLM). Ltrl is not affiliated with or endorsed by NLM.
Contact & Hours
Via practice · 2 locations total
- Address
- 214 SOUTH 4TH STREET
KREMMLING, CO 80459 - Phone
- (970) 887-5800
Quick Facts
- NPI
- 1871541201
- Entity Type
- Individual
- Gender
- Male
- Medicare
- Accepted
- Specialties
- 2
- Locations
- 2
- Years in Practice
- 36
- Publications
- 20
Are you this provider?
Claim Your Profile